Kyle Moran - 04 Feb 2025 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role
Chief Financial Officer
Signature
/s/ Kyle Moran
Issuer symbol
WVE
Transactions as of
04 Feb 2025
Net transactions value
$0
Form type
4
Filing time
06 Feb 2025, 20:00:09 UTC
Previous filing
11 Oct 2024
Next filing
10 Dec 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WVE Ordinary Shares Award $0 +42,000 +89% $0.000000 89,218 04 Feb 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WVE Share Option (right to buy) Award $0 +252,000 $0.000000 252,000 04 Feb 2025 Ordinary Shares 252,000 $11.74 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2026 through February 8, 2029.
F2 Includes 2,441 ordinary shares acquired on January 14, 2025, under the issuer's 2019 Employee Share Purchase Plan.
F3 The option vests as to 25% of the shares on February 8, 2026, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2029.